Investigating cell-free nucleic acids for cancer detection
Hypoxic induction of vasorin regulates Notch1 turnover
Final results of PERSIST-2 confirm benefit; PAC203 enrolling
Complex microsurgery may reduce risk of lymphedema
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Positive results point to a better prognosis for intractable disease
Multimodal analgesia under study
Discovery of mechanistic links may lead to new therapies
Cardiovascular drug affects cancer cell protein pathways
Study examines concordance between commercially available genomic tests
Cleveland Clinic researchers first to show sensitivity of IDH1/2 mutations to PARP inhibitor olaparib
Advertisement
Advertisement